Woodline Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Woodline Partners's LLY Position: Q1 2026 in Review
Woodline Partners increased its Eli Lilly (LLY) stake by 8.3% in Q1 2026, buying an estimated $17.9M and bringing the position to 230,474 shares worth $212M. The position accounts for 0.8% of the portfolio, ranked #12.
Woodline Partners first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $258M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Woodline Partners held 230,474 shares of Eli Lilly worth $212M as of Q1 2026.
- Woodline Partners bought 17,612 Eli Lilly shares in Q1 2026, an estimated $17.9M.
- Eli Lilly made up 0.8% of Woodline Partners's portfolio in Q1 2026, its #12 holding.
- Woodline Partners first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
- Woodline Partners's Eli Lilly position peaked at $258M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.